Samsung Bioepis Co., Ltd.

Samsung Bioepis Co., Ltd. logo
🇰🇷South Korea
Ownership
Subsidiary
Established
2012-01-01
Employees
501
Market Cap
-
Website
http://www.samsungbioepis.com
drugs.com
·

FDA Approves Epysqli (eculizumab-aagh), a Biosimilar to Soliris

FDA approves Epysqli (eculizumab-aagh), a biosimilar to Soliris for treating paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), based on evidence showing high similarity to Soliris without clinically meaningful differences in safety, purity, and potency.
© Copyright 2024. All Rights Reserved by MedPath